HEALTH● LOW1d ago · Oct 2, 2026, 4:08 PM
Pfizer says phase 3 data buoys Litfulo as a vitiligo treatment
Seeking Alpha Tech · global
Pfizer announced that positive Phase 3 trial data supports Litfulo's effectiveness as a treatment for vitiligo. This represents a development in medical research for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoIllinois catering business ordered to shut down after high school football team got sick before homecomingThe Independent WorldHEALTH1h agoMexican father and son win the race of life against heart diseaseClarínHEALTH1h agoFlorida’s dengue outbreak reportedly largest US has seen in decadesThe HillHEALTH1h agoAIIMS for Keralam: Kozhikode under active consideration, says SatheesanThe Hindu